The pitch sounds almost too neat: a color-changing biosensor that alerts farmers to crop disease days or even weeks before the first leaf spots or wilting stems appear. It's the kind of promise that could prevent billions in annual losses—or fizzle as another well-intentioned agtech prototype that never quite makes it past the greenhouse.
Viridys Bio, a young company tucked away in Exeter, is betting on the former. The startup has announced the first close of its pre-seed round, receiving £500,000 from SFC Capital, Carbon13, and a handful of angel investors. The round, announced in early June, remains open with roughly £130,000 still on the table—a detail that hints at either cautious momentum or lingering investor curiosity.
At the heart of Viridys Bio's technology is an idea borrowed from the plant world itself. When crops face stress—whether from fungal invaders, insect pests, or environmental strain—they release volatile organic compounds into the air. These VOCs are invisible signals, chemical distress flares that most growers never detect until visible damage has already set in. Viridys is engineering microbial biosensors to pick up those signatures early, translating them into a simple color shift that requires no lab analysis, no connectivity, no app. Just a visual cue.
It's a distinct approach in a field crowded with competing visions of early detection. Some startups are deploying AI-powered cameras to scan for pixel-level anomalies; others are installing automated spore traps or sensor networks. Scanit Technologies, for instance, launched its spore-detection system on July 1. Viridys is wagering that microbial sensing of plant volatiles can beat those methods on two fronts: earlier warnings and lower cost.
The stakes are considerable. The Food and Agriculture Organization notes that up to 40% of crops are lost to pests and diseases annually, with above $220 billion in trade losses. For greenhouse operators or orchard managers working on thin margins, even a modest improvement in early detection could be transformative.
Two Founders, Two Worlds
Viridys Bio was incorporated on January 23, 2025, a collaboration between two founders whose résumés don't immediately suggest agtech. CEO Stuart Dixon spent 11 years at Goldman Sachs, rising to Executive Director, with an earlier stint as a British Army officer. His co-founder, Dr. Rotem Berman, comes from a different universe entirely: more than two decades in deep tech R&D, much of it in defense applications.
Berman's background is particularly unusual for the agtech world. He previously led biosensor programs at Rafael Advanced Defense Systems, the Israeli defense contractor, and managed what the company describes as the first operational deployment of biosensors for landmine detection—a project undertaken with the Israeli Ministry of Defense and Hebrew University. He holds a PhD in Physics from Technion. It's the kind of technical pedigree that raises questions about whether biosensors hardened for battlefield conditions can be adapted for the softer demands of agriculture. Or perhaps the better question: whether that rigor is exactly what's needed.
Co-Designing With Growers
The £500,000 will go toward advancing the biosensor platform itself—prototype refinement, controlled environment trials, the usual pre-seed milestones. But Viridys has also been doing something smarter than many early-stage hardware companies: co-designing with potential customers before the product is fully baked.
The company's website lists partnerships spanning the UK agri-food sector. There's the University of Exeter, naturally, along with the UK Agri-Tech Centre. More tellingly, Viridys has forged relationships with commercial growers—Thanet Earth and Suffolk Fresh, both major greenhouse operators—as well as the British Tomato Growers Association and Agromillora, a global fruit-tree nursery. These aren't casual letters of intent. They suggest Viridys is testing its assumptions against the realities of commercial growing operations, perhaps more than the founders initially expected.
SFC Capital, which has backed over 500 UK startups since 2012, led the round. Carbon13 came in through its SEIS Fund IX, which focuses on climate ventures. In July, IFA Magazine reported that Viridys had entered Carbon13's 12-month Growth Phase alongside four other climate tech companies—a structured program that offers more than just capital. The company has also secured SEIS Advance Assurance, unlocking UK tax incentives for early investors. That administrative detail matters: it smooths the path for additional angel participation as the round closes out.
The Hard Part Ahead
Controlled environment trials are the next milestone. That's where the technology either demonstrates it can reliably distinguish between, say, early blight and nutrient deficiency—or it doesn't. The synthetic biology underpinning these sensors is elegant in theory, but agriculture is notoriously unforgiving when it comes to false positives or sensors that degrade in humid, dirty conditions.
And then there's the question of market fit. Growers, especially those operating greenhouses or high-value crops, are accustomed to sophisticated integrated pest management systems. Convincing them to adopt a new detection method means proving not just that it works, but that it integrates smoothly into existing workflows without adding friction or cost.
Still, if Viridys can demonstrate that its biosensors deliver on their promise—catching disease before human eyes can see it, at a price point that makes sense for commercial operations—it could carve out a meaningful niche in an industry desperate for better tools. The alternative is another cautionary tale about agtech hardware that looked brilliant in the lab but stumbled in the field.
For now, Viridys Bio is somewhere between those two outcomes. The first £500,000 is in. The next phase will reveal whether the technology holds up—and whether growers will trust a color-changing biosensor over their own instincts.
